Drug-induced psychosis happens when a substance triggers hallucinations, delusions, or both, either during intoxication or within a month of use or withdrawal. It can be caused by illegal drugs, prescription medications, and even some over-the-counter products. The specific mechanism depends on the substance, but the common thread is a disruption in how the brain processes reality, primarily through two chemical signaling systems: dopamine and glutamate.
How Substances Disrupt Brain Signaling
Most drug-induced psychosis traces back to one of two pathways in the brain. The first involves dopamine, a chemical messenger tied to motivation, reward, and the filtering of sensory information. When a drug floods the brain with dopamine or makes dopamine receptors overly sensitive, the result can be paranoid thinking, hearing voices, or believing things that aren’t real. This is the primary mechanism behind stimulant-triggered psychosis and is also the reason all current antipsychotic medications work by blocking dopamine receptors.
The second pathway involves glutamate, the brain’s main excitatory signal, and a specific type of receptor it acts on. Drugs like ketamine and PCP block these receptors, which disrupts communication between brain regions, particularly in the thalamus, a structure that acts as a relay station for sensory information. When that relay is jammed, the brain can produce sensory illusions, paranoid ideas, poor attention, difficulty finding words, and trouble learning new information. Research in the early 1990s demonstrated that even a single low-dose ketamine infusion in healthy adults produced transient psychotic symptoms, confirming how potent this mechanism is.
Stimulants: Amphetamines, Methamphetamine, and Cocaine
Stimulants are among the most common triggers. Amphetamines and methamphetamine cause a massive surge of dopamine, and at high enough doses or after prolonged use, this can push the brain into a psychotic state. Symptoms typically include intense paranoia, auditory hallucinations, and agitation. Methamphetamine is particularly notorious because its effects last many hours, giving the brain a prolonged dopamine flood that is harder to recover from.
Cocaine works through a similar dopamine mechanism but with a shorter duration of action, meaning psychotic episodes tied to cocaine tend to be briefer. Still, binge patterns of cocaine use can sustain psychotic symptoms for days. Among adolescents and young adults with ADHD taking prescription stimulants at therapeutic doses, new-onset psychosis occurred in roughly 1 in 660 patients, a figure from a large study published in the New England Journal of Medicine. That rate is low, but it illustrates that even medically supervised, standard-dose stimulant use carries some risk.
Cannabis and Synthetic Cannabinoids
THC, the psychoactive component in cannabis, can trigger psychotic symptoms, especially at high concentrations. The risk rises with potency, frequency of use, and the age at which a person starts. Genetics also play a role. A specific variation in a gene that controls how dopamine is broken down in the brain appears to amplify the effect: people who carry certain versions of this gene and use cannabis regularly experience more severe psychotic symptoms than those who don’t carry the variant, with the effect becoming stronger if both copies of the gene are the higher-risk version.
Synthetic cannabinoids, sold under names like Spice or K2, are considerably more dangerous than natural cannabis in this regard. These lab-made compounds bind to the same brain receptors as THC but with far greater intensity. In studies comparing first-episode psychosis across groups, synthetic cannabinoid users displayed much more severe hallucinations and delusions than either natural cannabis users or people who developed psychosis without any substance use. Suicidal thinking was also higher in the synthetic cannabinoid group. Perhaps most concerning, after nine months of follow-up, people whose psychosis was linked to synthetic cannabinoids had recovered significantly less in their daily functioning compared to non-users.
Dissociative Drugs: Ketamine and PCP
Ketamine and PCP (phencyclidine) cause psychosis through a different mechanism than stimulants. Rather than flooding the brain with dopamine, they block glutamate receptors in a way that disrupts the thalamus, the brain’s sensory gatekeeper. The result is a distinctive set of symptoms: a detached, dreamlike state combined with paranoid ideas, sensory distortions, and cognitive impairment. PCP tends to produce more prolonged and aggressive psychotic episodes than ketamine, partly because it lingers in the body longer. Several other research chemicals that block the same receptor type reproduce these effects in both humans and animals, confirming that this receptor blockade is the core cause.
Prescription Medications
Psychosis isn’t limited to recreational drugs. Several classes of prescription medication can trigger it as a side effect. Corticosteroids, commonly prescribed for inflammation, autoimmune conditions, and respiratory illness, are a well-documented cause. In case reports, patients as young as four have developed psychotic symptoms after receiving standard doses of steroids for conditions like croup or nephrotic syndrome. A 16-year-old patient with Crohn’s disease developed auditory hallucinations and disordered thinking after just two weeks on a standard steroid dose.
Medications with anticholinergic effects, which block a neurotransmitter involved in memory and attention, can also cause psychosis. These drugs are found in some muscle relaxants, antihistamines, bladder medications, and older antidepressants. The range of possible effects on the brain is broad: anxiety, disorientation, visual hallucinations, bizarre behavior, delirium, and in severe cases, psychosis or seizures. The risk generally increases with dose and is higher in older adults, whose brains are more sensitive to anticholinergic effects.
Risk Factors Beyond the Drug Itself
The substance alone doesn’t tell the whole story. Several factors make one person more vulnerable than another to a psychotic break.
- Genetics: A family history of psychotic illness significantly raises the risk. Gene variants affecting dopamine metabolism, like the one linked to cannabis psychosis, can determine whether a substance tips someone over the threshold.
- Sleep deprivation: Going without sleep for extended periods, which often accompanies stimulant binges, independently destabilizes the brain’s ability to distinguish real from unreal. Combined with a drug’s effects, this can accelerate the onset of psychosis.
- Poly-substance use: Using multiple substances at once compounds the neurochemical disruption. Mixing stimulants with cannabis or alcohol with hallucinogens creates unpredictable interactions that raise psychosis risk beyond what either drug would cause alone.
- Age of first use: The adolescent brain is still developing its dopamine and glutamate systems. Early exposure to psychoactive substances during this window increases vulnerability to psychotic episodes both immediately and later in life.
- Pre-existing mental health conditions: People already experiencing subclinical symptoms, such as unusual perceptual experiences or mild paranoia, are at higher risk of a full psychotic episode when exposed to triggering substances.
How It Differs From Schizophrenia
The key distinction is timing. Drug-induced psychosis, by definition, develops during or within a month of substance intoxication or withdrawal, and it does not occur exclusively during delirium. The symptoms, hallucinations and delusions, can look identical to schizophrenia. But in a substance-induced episode, those symptoms typically appear quickly and resolve within days to weeks once the drug clears the system. Primary psychotic disorders like schizophrenia also tend to include “negative” symptoms like emotional flatness, social withdrawal, and loss of motivation, which are less prominent in drug-induced cases.
Clinicians distinguish between the two by looking at the timeline: did symptoms start before or after substance use? Do they persist long after the drug has left the body? If psychotic symptoms continue well beyond the withdrawal window, the diagnosis may shift toward a primary psychotic disorder.
The Risk of Long-Term Psychotic Illness
One of the most important things to understand about drug-induced psychosis is that it doesn’t always stay drug-induced. A major meta-analysis pooling data across studies with an average follow-up of four years found that 25% of people diagnosed with substance-induced psychosis eventually transitioned to a schizophrenia diagnosis. That’s one in four. The transition rate was slightly lower in older patients but was not affected by sex, country, urban versus rural setting, or how long researchers followed up.
This means a drug-induced psychotic episode can be an early signal that a person was already vulnerable to a chronic psychotic illness, with the substance acting as the trigger that set it in motion. Cannabis-induced psychosis has among the highest conversion rates, while alcohol-induced psychosis tends to have a somewhat lower rate. For anyone who has experienced even a single episode, this statistic underscores why continued substance use is a serious gamble with long-term mental health.